The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 16, 2026
Filed:
May. 14, 2025
Applicant:
Kaken Pharmaceutical Co., Ltd., Tokyo, JP;
Inventors:
Assignee:
Kaken Pharmaceutical Co., Ltd., Tokyo, JP;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/04 (2006.01); A61K 31/404 (2006.01); A61K 31/4184 (2006.01); A61K 31/4192 (2006.01); A61K 31/4196 (2006.01); A61K 31/4245 (2006.01); A61K 31/427 (2006.01); A61K 31/433 (2006.01); A61K 31/437 (2006.01); A61K 31/4439 (2006.01); A61K 31/444 (2006.01); A61K 31/4725 (2006.01); A61K 31/501 (2006.01); A61K 31/513 (2006.01); A61K 31/5377 (2006.01); C07D 235/14 (2006.01); C07D 401/04 (2006.01); C07D 401/14 (2006.01); C07D 403/04 (2006.01); C07D 403/10 (2006.01); C07D 403/14 (2006.01); C07D 405/04 (2006.01); C07D 413/10 (2006.01); C07D 417/14 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); A61K 31/404 (2013.01); A61K 31/4184 (2013.01); A61K 31/4192 (2013.01); A61K 31/4196 (2013.01); A61K 31/4245 (2013.01); A61K 31/427 (2013.01); A61K 31/433 (2013.01); A61K 31/437 (2013.01); A61K 31/4439 (2013.01); A61K 31/444 (2013.01); A61K 31/4725 (2013.01); A61K 31/501 (2013.01); A61K 31/513 (2013.01); A61K 31/5377 (2013.01); C07D 235/14 (2013.01); C07D 401/04 (2013.01); C07D 401/14 (2013.01); C07D 403/04 (2013.01); C07D 403/10 (2013.01); C07D 403/14 (2013.01); C07D 405/04 (2013.01); C07D 413/10 (2013.01); C07D 417/14 (2013.01);
Abstract
The present invention provides a novel compound that has STAT6 inhibitory activity and is effective for treatment of inflammatory diseases such as atopic dermatitis and for allergic diseases. A compound pharmaceutically acceptable salt thereof expressed by general formula (I) having STAT6 inhibitory activity.
Sumikawa, Yoshitake. (2026). Fused ring compound and pharmaceutical containing same (U.S. Patent No. 12655147). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12655147
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile